- Home
- CABO vs ZLAB Comparison
CABO vs ZLAB Comparison
Compare CABO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CABO | ZLAB |
|---|---|---|
| Founded | 1980 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 641.2M | 1.8B |
| IPO Year | 2015 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CABO | ZLAB |
|---|---|---|
| Price | $92.01 | $17.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $125.67 | $49.60 |
| AVG Volume (30 Days) | 132.9K | ★ 639.7K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,501,423,000.00 | $460,156,000.00 |
| Revenue This Year | N/A | $14.46 |
| Revenue Next Year | $3.67 | $29.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $70.37 | $15.96 |
| 52 Week High | $277.97 | $44.34 |
Technical Indicators
Market Signals| Indicator | CABO | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 38.56 |
| Support Level | $85.45 | $17.03 |
| Resistance Level | $116.36 | $19.71 |
| Average True Range (ATR) | 8.52 | 0.66 |
| MACD | -2.12 | -0.17 |
| Stochastic Oscillator | 7.69 | 4.07 |
Price Performance
Historical ComparisonAbout CABO Cable One Inc.
Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.